Online Inquiry
Cat.#: ACPP-1213
| Despition | CACNB2 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1160 | Recombinant Human GPCR GPR20 Protein (Fc Tag) (AC1160) | 50 µg | inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1717 | Mouse LIF Protein (AC1717) | 3 x 2 µg | inquiry |
| ACPP-1420 | MOG (AC1420) | 5 mg | inquiry |
| ACPP-1449 | Human IL 6 Protein, CHO (AC1449) | 5 µg | inquiry |
| ACPP-1551 | Human PEDF Protein, His (AC1551) | 5 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.